Based on our many years of experience with a variety of cells, EUFETS has established a technology platform for the cultivation and genetic modification of cells from a small scale to clinically relevant scales in closed systems according to cGMP guidelines.

Our technology platform is not restricted to haematopoietic cells but can be exploited for a variety of primary cells and cell lines. Depending on your utilized cell type we adopt the culturing system and cell culture conditions in order to maximize productivity.

Genetic modification with your favoured method (retroviral, non-viral) or differentiation of cells can be part of the culturing process as desired.